STUB1 and coronary artery disorder: Three-year all-cause mortality was increased in CAD patients carrying any CHIP mutation (n = 301; 12.6%) compared with matched CAD controls (n = 218; 9.1%) [HR 1.39, 95% confidence interval (CI) 1.16–1.65] (Figure 2 ).